ANNOUNCING MEDCANN PHARMA AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING MEDCANN PHARMA AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce medcann pharma as a Bronze Partner for our London conference this June at the Southbank Centre. medcann is a Canadian registered company with its roots firmly in Colombia, dedicated to a long-term strategy to be a fully integrated medicinal cannabis company. Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe, dedicated to creating a platform for European leadership in the global cannabis industry. Leaders gather for thought-provoking panel discussions that aim to solve uniquely European issues facing this nascent industry, welcoming medcann as a leader...

ANNOUNCING VALENS AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING VALENS AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Valens as a Silver Partner for our London conference this June at the Southbank Centre. Valens is a British-Columbia based company specialising in extraction, testing, formulation and product developmentof medical cannabis. With partnerships across the world and plans to process in Europe under EU GMP certification, achieving the highest quality is personal, and what makes Valens the “best in class”. Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe, dedicated to creating a platform for European leadership in the global cannabis industry. Leaders gather for...

EUROPEAN CANNABIS PATIENT EXPERIENCES

EUROPEAN CANNABIS PATIENT EXPERIENCES

By Bill Griffin Patients will benefit from cannabis at a consistent rate across Europe. Sadly, medical cannabis is far from harmonised at an EU level, resulting in very different patient experiences depending on which country you live in. As Cannabis Europa approaches, our correspondent, Bill Griffin, details five patient stories from across the continent, showing the lack of consistency in both prescriptions and product. GERMANY: RICHARD Richard is an expat living in Germany. He was seeking medical cannabis to ease the discomfort he suffered after a bout of Lyme disease and an operation to remove 25cm of his colon. He...

ANNOUNCING PRØHBTD AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING PRØHBTD AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce PRØHBTD as a Bronze Partner for our London conference this June at the Southbank Centre. PRØHBTD is a hybrid consumer goods and content company recognised as the exclusive global cannabis partner of Licensing Expo, Advertising Week, All Def Media, Postmedia, and Entrepreneur Magazine. The company is venture-backed with over USD $20 Million in funding and has offices in Los Angeles, Toronto, New York and Vancouver. Cannabis Europa is the foremost arena to share knowledge and shape the future of cannabis policy in Europe, dedicated to creating a platform for European leadership and paving the...

ANNOUNCING CANNAMEDICAL® PHARMA AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING CANNAMEDICAL® PHARMA AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Cannamedical® Pharma as a Bronze Partner for our London conference this June at the Southbank Centre. Cannamedical® Pharma is a GDP-certified and fully licensed pharmaceutical wholesaler in accordance with the German Medicines Act (AMG) and licensed narcotics dealer in accordance with the German Narcotics Legislation. In addition, the company is permitted to import narcotic medicines into Germany and export to member states of the European Union (EU) and beyond. Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe, dedicated to creating a platform for European...

ANNOUNCING CLEVER LEAVES AS A POST-CONFERENCE DRINKS PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING CLEVER LEAVES AS A POST-CONFERENCE DRINKS PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Clever Leaves and its brand Esenia as a Post-Conference Drinks Partner for day one of our London conference this June at the Southbank Centre. Clever Leaves is a vertically-integrated licensed producer of medical cannabis in Colombia. Clever Leaves objective is to become the biggest medical cannabis company in the world, with more than 100 hectares of cultivated land, state of the art laboratory, GACP and GMP certified, assuring the highest quality standards in the field. Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe, dedicated...

ANNOUNCING THE SUPREME CANNABIS COMPANY INC. AS THE GOLD PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING THE SUPREME CANNABIS COMPANY INC. AS THE GOLD PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce The Supreme Cannabis Company, Inc. as the Gold Partner for our London conference this June at the Southbank Centre. The Supreme Cannabis Company, Inc. (TSX: FIRE), is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, Supreme has emerged as one of the world’s fastest-growing, premium plant driven-lifestyle companies by effectively deploying capital, with an emphasis on disciplined growth and high-quality products. “We live in such an exciting time; we are part of an industry that is growing at unprecedented rates and has the opportunity to deliver many positive benefits...

ANNOUNCING DRAGONFLY AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING DRAGONFLY AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Dragonfly Biosciences as a Bronze Partner for our London conference this June at the Southbank Centre. Dragonfly Biosciences is Europe’s largest and leading producer of cannabidiol (CBD) and cannabis-derived extracts. After rapid growth in the past two years, it now boasts a head office in London, farms and formulation facilities in Bulgaria, and partner companies in Poland, Canada and Malta. A seed-to-sale producer, Dragonfly’s reach is bolstered by 650 hectares of organically certified, fully irrigated farmland – a capacity soon to rise. Cannabis Europa is the foremost arena to share knowledge and shape the...

ANNOUNCING TORONTO STOCK EXCHANGE AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING TORONTO STOCK EXCHANGE AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Toronto Stock Exchange as a Bronze Partner for our London conference this June at the Southbank Centre. Canada’s premier equities exchanges, Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) are home to over 3,000 listed companies with a total market capitalisation of almost $3 trillion (CAD). Together, TSX and TSXV represent the world’s most successful two-tiered ecosystem for supporting the long-term success of issuers across a wide range of sectors, with over 650 companies graduating from the junior to the senior market since 2001. Cannabis Europa is the foremost arena to share knowledge...

ANNOUNCING CANNEX CAPITAL/4FRONT VENTURES AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING CANNEX CAPITAL/4FRONT VENTURES AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Cannex Capital / 4Front as a Bronze Partner for our London conference this June at the Southbank Centre. The British Colombia-based Cannex Capital and US-based 4Front pending partnership encompasses proven management and operational skills in large-scale indoor cultivation facilities that boast industry-leading yields, the manufacturing and branding of infused products, edibles and other derivative products, and proven experience managing curated customer-centric retail operations. Cannex Capital / 4Front will create a multi-state vertically integrated powerhouse, serving as an example of how to achieve excellence through partnership. “We look forward to bringing our experience in the...

ANNOUNCING MGC PHARMACEUTICALS AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING MGC PHARMACEUTICALS AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce MGC Pharmaceuticals as a Silver Partner for our London conference this June at the Southbank Centre. MGC Pharmaceuticals (ASX:MXC, OTC US: MGCLF) is an EU based bio-pharma company, creating a seamless pipeline of high quality, pharmaceutical grade products, taking advantage of the medical value of phytocannabinoids. MGC Pharma’s goal is to facilitate the transformation of phytocannabinoids into true medicinal product pipelines, and to provide breakthrough solutions for prevalent global health issues to improve the quality of patients’ lives. Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis...

HEALTH-TECH AND BIG DATA: SHAPING THE MODERN CANNABIS INDUSTRY

HEALTH-TECH AND BIG DATA: SHAPING THE MODERN CANNABIS INDUSTRY

Medical cannabis has the opportunity to be the first modern medical industry that is built with a digital-first approach. Technology is already providing ways to educate people, empower patients, fuel innovation and feedback into the product development cycle. For example, while governments struggle to develop the infrastructure for a medical cannabis industry – or indeed even drag their feet in terms of acknowledging the medical benefits of cannabis-based products – the Internet can provide information and education. In the UK, patients are struggling to access medical cannabis partly due to a lack of training and knowledge in the medical community...

CBD AND SPORT: PERMEATING THE MAINSTREAM

CBD AND SPORT: PERMEATING THE MAINSTREAM

As CBD has permeated popular consciousness, athletes across the world have shared stories about how they use CBD and cannabis products as part of their training and recovery. As sales and popularity soar, consumers and brands are pushing regulators to keep up with the industry. In January 2018, cannabidiol (commonly known as CBD) was removed from the World Anti-Doping Agency’s (WADA) list of banned substances. WADA, led by the International Olympic Committee (IOC), is responsible for the World Anti-Doping Code which aims to harmonise anti-doping regulations in all sports and countries. It has been adopted by more than 600 sports...

ANNOUNCING HEXO CORP. AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING HEXO CORP. AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce HEXO as a bronze partner for our London conference this June at Southbank Centre. HEXO Corp is an award-winning Canadian medical and adult-use cannabis company and home to Elixir CBD – winner of Innovation of the Year and Cannabis Product of the Year (2018 Canadian Cannabis Awards). “Cannabis Europa is a unique and forward-thinking opportunity for the emerging EU cannabis industry and the established Canadian industry to gather, share and learn from each other. HEXO is very excited to join the conversation and support this wonderful event.” — HEXO TEAM Cannabis Europa is proud...

ANNOUNCING MEMERY CRYSTAL AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING MEMERY CRYSTAL AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Memery Crystal as a Silver Partner for our London conference this June at the Southbank Centre. Memery Crystal is the leading UK law firm in the cannabis sector, advising on business set-up, capital markets, mergers and acquisitions, private fundraising, licensing and commercial contracts. “We are looking forward to attending the event and sharing our expertise with like-minded organisations and individuals from across Europe,” says Simon Bastin, Business Development Director. At the Forefront Cannabis Europa is Europe’s premier medical cannabis conference and the foremost arena to share knowledge and shape the future of the industry...

TWELVE MONTHS IN MEDICAL CANNABIS

TWELVE MONTHS IN MEDICAL CANNABIS

One year on since the inaugural Cannabis Europa in London, the landscape of the European cannabis industry has changed dramatically. This time 12 months ago, medical cannabis was still illegal in the UK, Belgium, Luxembourg, Portugal and Greece despite growing momentum behind legalisation campaigns. A YEAR IN REVIEW On 21st-22nd May 2018, over 400 industry insiders gathered at Europe’s premier medical cannabis conference to discuss the future of medical cannabis in Europe. Patients, doctors, researchers, politicians, policymakers and entrepreneurs from around the world gathered at the Barbican in London to attend the first ever Cannabis Europa. There were a number...

THE VALUE OF BEING A FIRST MOVER IN CANNABIS

THE VALUE OF BEING A FIRST MOVER IN CANNABIS

Right now, the cannabis industry is so new that being a part of it makes you a first mover by default. The paradox of being a first mover is that by definition you pave the way. Your costs are going to be higher and your resources more thinly spread. They make, and pay for, the mistakes that others witness and navigate around. In 2001, Canada became the first country in the world to legalise medical cannabis. Seventeen years later, they became the second country in the world to legalise recreational cannabis. While much of the international cannabis community heralded the...

ANNOUNCING EMMAC LIFE SCIENCES AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING EMMAC LIFE SCIENCES AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce EMMAC Life Sciences as a Silver Partner for our London conference this June at the Southbank Centre. EMMAC Life Sciences is an independent European medical cannabis company, combining the latest science and research with cutting-edge cultivation, extraction and production. Spearheading Relief for UK Patients This April, EMMAC announced the acquisition of Rokshaw, a leading UK Specials manufacturer, enabling the company to import medical cannabis into the UK to meet the growing demand for premium medical cannabis products. EMMAC aims to close the gap between cannabis policy reform and the subsequent lack of patients access...

ANNOUNCING AURORA AS THE HEADLINE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING AURORA AS THE HEADLINE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Aurora as the Headline Partner for our London conference this June at the Southbank Centre. With operations in 24 countries, Aurora is at the forefront of the growing global medical cannabis industry. Aurora was an early entrant into the European market, supplying patients in Germany with high-quality medical cannabis since 2015. Aurora Europe, along with its subsidiary Aurora Deutschland, is now the largest authorised importer, exporter, and distributor of EU-GMP certified medical cannabis in the European Union. This footprint continues to grow, with Aurora’s recent public tender win in Germany, enabling the Company to...

HOW CLOSE IS EUROPEAN HARMONISATION ON MEDICAL CANNABIS?

HOW CLOSE IS EUROPEAN HARMONISATION ON MEDICAL CANNABIS?

On the face of it, the European medical cannabis scene looks rosy – people often state that over 20 EU countries have legalised medical cannabis in some form or another. Dig a little deeper and you discover in many cases ‘some form or another’ can be a far cry from what a patient actually needs. According to MJBiz Daily, once you exclude Sativex or synthetic cannabinoids, only three countries in Europe – Germany, Italy and the Netherlands – have any meaningful sales of medical cannabis. Depending on where you live in Europe, being a medical cannabis patient – or someone...